BAFNAPH — Bafna Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹2.05bn
- IN₹2.14bn
- IN₹1.15bn
- 35
- 41
- 34
- 25
Annual cashflow statement for Bafna Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2019 March 31st | C2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -183 | -18.8 | 58.3 | 51.9 | 118 |
| Depreciation | |||||
| Non-Cash Items | 19.7 | -235 | -6.61 | 15.7 | 16.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 111 | -122 | -233 | -25.3 | -138 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -17.9 | -343 | -136 | 97.3 | 49.5 |
| Capital Expenditures | -3.33 | -14.3 | -60.9 | -75.4 | -82.2 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 157 | 342 | 7.49 | 9.97 | 7.26 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 154 | 328 | -53.5 | -65.4 | -74.9 |
| Financing Cash Flow Items | -25.6 | -48.4 | -0.886 | -0.882 | -16.9 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -138 | 72.7 | 123 | -48.1 | 102 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.38 | 57.8 | -66.8 | -16.3 | 76.4 |